Evaluation of the Relationship Between Serum Level of Vitamin B۱۲ and Prognostic Indicators of Breast Cancer in Semnan

سال انتشار: 1400
نوع سند: مقاله کنفرانسی
زبان: انگلیسی
مشاهده: 147

نسخه کامل این مقاله ارائه نشده است و در دسترس نمی باشد

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این مقاله:

شناسه ملی سند علمی:

CSUMSMED07_172

تاریخ نمایه سازی: 20 دی 1401

چکیده مقاله:

Introduction: Breast cancer is the most common cancer and the leading cause of cancer death among women in the world. Given the potential relationship between vitamin B۱۲ deficiency and cancer progression, the present study investigated the possible relationship between vitamin B۱۲ deficiency and some of the factors affecting the prognosis of breast cancer. Materials and Methods: This cross-sectional and descriptive-analytical study was performed on ۶۳ patients with breast cancer who met the inclusion criteria. Serum levels of vitamin B۱۲ were requested for all patients and the required information was collected in the relevant forms. The relationship between serum vitamin levels and desired factors was investigated by relevant statistical tests. Results: It was found that only ۱۵.۹% of breast cancer patients had normal serum levels of vitamin B۱۲ and others had some degree of deficiency. There was also an inverse relationship between age and serum levels of vitamin B۱۲, but this relationship was not statistically significant (P=۰.۸۵۵). It was also found that the serum level of vitamin B۱۲ is significant with tumor status in terms of PR (P=۰.۰۳) and it is notablewith tumor status in terms of ER (P=۰.۰۹). Conclusion: Considering the significant relationship between serum levels of vitamin B۱۲ and PR in breast cancer, further studies with larger sample sizes are suggested to clarify the relationship between these two factors.

نویسندگان

Atousa Najmaldin

Department of Internal Medicine, Semnan University of Medical Sciences, Semnan, Iran

Malihe Azadehrah

Assistant professor, Gynecologic Oncosurgeon, Cancer Research Center, Golestan University of Medical Science, Gorgan, Iran

Sepideh Karvanian

Department of internal medicine, School of Medicine, Semnan University of Medical Sciences, Semnan, Iran

Farahnaz Ghahremanfard

Oncologist, Associate Professor, Cancer Research Center (CRC), Semnan University of Medical Sciences, Semnan, IranHematologist & Sciences, Semnan, Iran